Using a standardized treatment system for acute ischemic stroke in Xi'an

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the real-world application of a standardized green channel treatment system for patients with acute ischemic stroke in Xi'an. It involves collecting clinical data from patients who received this treatment within 24 hours of stroke onset. The study will assess various outcomes, including prognosis, mortality rates, incidence of cerebral hemorrhage, pneumonia, and stroke recurrence after 90 days. The approach emphasizes rapid assessment and intervention to improve patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years old;
* Consistent with the diagnosis of acute ischemic stroke;
* 24 hours from onset to enrollment;
* Informed consent

Exclusion Criteria:

* Patients who refuse to receive intravenous thrombolysis or intravascular intervention (including intravascular mechanical thrombolysis and arterial thrombolysis);
* Stroke patients caused by brain tumor, brain trauma and blood diseases;
* Those with a history of stroke and sequelae affecting the outcome assessment, namely, mRS 2 points before the onset of this stroke;
* Combined with claudication osteoarthritis rheumatoid arthritis gout arthritis and other limb dysfunction and affect the neurological function examination;
* Patients with severe hepatic and renal insufficiency (Note: Hepatic insufficiency refers to ALT or AST values greater than 2 times the upper normal limit; Renal insufficiency refers to blood creatinine value greater than 2 times the normal upper limit);
* Suffering from other serious life-threatening diseases with an expected survival time of less than 3 months;
* Other diseases that limit neurological function evaluation or affect patient follow-up;
* A woman planning to be pregnant or breastfeeding;
* Currently participating in other clinical trials;
* Refuse to participate in the registration of investigators

Where it's running

• Xi 'an No.3 Hospital
  Xi'an, Shaanxi, China Recruiting

Study contacts

• Study coordinator: Mingze Chang, Doctor
• Email: changmingze191@163.com
• Phone: 8615609250698

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• IV thrombolysis for branch atheromatous stroke in deep brain arteries

  This study looks at whether intravenous thrombolysis can help people with branch atheromatous disease-related stroke compared with standard antiplatelet therapies.

  Recruiting at 6 sites Sigmund Freud PrivatUniversitat · Vienna, State of Vienna and 7 other locations · NCT07299994

• Blood pressure management during early clot‑busting treatment for acute ischemic stroke

  This trial will test whether an adjusted blood pressure approach is safer than usual care for people with acute ischemic stroke who are receiving IV thrombolysis and have high blood pressure.

  Recruiting Phase 2 Shanghai East Hospital · Shanghai · NCT07279259

• Short-Term outside-in nerve stimulation for acute ischemic stroke

  This trial tests whether a 5-day external trigeminal nerve stimulation given after stroke can help more patients recover better than a sham treatment.

  Recruiting Xidian University · Xi'an · NCT07911605

• Sevoflurane vs. Propofol for anesthesia in stroke patients undergoing clot-removal

  This study tests whether sevoflurane or propofol used for anesthesia during endovascular treatment of an acute ischemic stroke affects the final brain damage and recovery.

  Recruiting Phase 3 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Barcelona · NCT07902791

• Safety of adding NRICM301 to standard care for adults with acute ischemic stroke

  This study tests whether adding NRICM301, a traditional Chinese medicine formula, to usual care is safe for adults with acute ischemic stroke.

  Recruiting En Chu Kong Hospital · New Taipei City · NCT07900503

• Intracranial Recanalization with LT3001 in Acute Ischemic Stroke

  This phase II study tests whether LT3001 given to adults with acute ischemic stroke can help reopen blocked brain arteries.

  Recruiting Phase 2 Lumosa Therapeutics Co., Ltd. · Taichung · NCT07890298

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.